A number of gene therapies are in late-stage clinical trials and expected to reach the market in the next several years.PAP-Q4-17-CL-002
Keeping up with quality is key for the industry throughout the supply chain. Quality must be ensured from the earliest phases of development.PAP-Q4-17-FA-001
The (bio)pharmaceutical industry is becoming a high-technology sector with success directly linked to innovation.PAP-Q4-17-NO-001
Lack of effective management of the outbound distribution of clinical trial materials can negatively impact study outcomes.PAP-Q4-17-CL-001
The contract manufacturing market for antibody-drug conjugates has huge potential, but an extraordinary range of capabilities is essential to be in the game.PAP-Q04-17-VP-001
Efficient development of optimal routes and manufacturing processes for the production of increasingly complex small molecule APIs requires extensive expertise.PAP-Q4-17-CL-003
Following a string of approvals, biosimilars are positioned to go the way of generics.PAP-Q4-17-FA-002
Call it the automation of everything — a hands-off approach will permeate supply chains in the near future.PAP-Q4-17-FA-003
Potassium channels are present in nearly all types of cells and involved in most physiological functions.PAP-Q4-17-CL-004
Reducing the time, cost and environmental footprint of manufacturing processes continues to be a major driver of technology development.PAP-Q3-17-CL-003
Single-use technologies (SUTs) have introduced a broad range of cost and operating efficiencies to bioprocessing operations.PAP-Q4-17-CL-006
Anticipating 2018 technologies and their impact.PAP-Q4-17-RT-002
Q: What do you see as being the most innovative technologies introduced in 2017? Why were they important? What impacts did they have?
The importance and impact on innovative technologies introduced in 2017.PAP-Q4-17-RT-001
Optimizing API Production as a True Manufacturing Partner
Jim Scandura, Executive Vice President, Chief Operating Officer at Avara Pharmaceutical Service discusses serving as a partner for API production.
Meeting Customer Needs
James E. Gregory, President and CEO of UPM Pharmaceuticals explains how to adapt to client expectations.
Providing a Complete Modular Solution
George Wiker, Executive Director at AES, explains the company's complete in-house offering.
ZUMA-1 Study of Yescarta Reports 58% Complete Remission
Long-term data presented at the American Society of Hematology Annual Meeting.
Phase II Results Reveal High-Performance Immunotherapy
RA drug nearly eliminates Graft-Versus-Host disease.
Emerging Lyme Disease Tests Found Efficacious
Expert multidisciplinary team finds next-gen diagnostics ready for clinicians.
Transforming the Pharmaceutical Industry Pipeline with In Silico Approaches
Icagen Inc. explains supporting an in silico drug discovery program.
Big Data: A Big Challenge
There is almost no aspect of the life sciences and related industries that Big Data cannot impact.
BIO World Congress on Industrial Biotechnology Announces Call for Presentations
The Biotechnology Innovation Organization (BIO) today issued a call for presentations for the 2018 BIO World Congress on Industrial Biotechnology.
CRB on the Road to BIO: Making Your Facility a Future Facility
Matthew Kennedy, Process Specialist, Senior Associate at CRB comments on overcoming challenges for clients, including investment uncertainty.
Fit Biopharmaceutical Facilities: A Predictive Maintenance Approach
Andrew Harris, Associate, Lead Process Engineer and Joe Povenski, Process Specialist for CRB USA explain maintaining facilities.
Sustainable Strategies for Contract Development and Manufacturing Service Growth
Members of the “Who’s Who” of CMO/CDMO leadership are pursuing robust growth strategies to keep the CDMO segment energized and interesting.
Genentech and Biothera to Assess Combination Cancer Therapy
Genentech to conduct trial to assess two of its antibodies with Biothera’s Imprime PPG for the treatment of metastatic colorectal cancer.
Vetter Begins Construction of Packaging Facility Expansion
New capabilities are being added to meet the growing need for complex packaging solutions.
Generic Firms Developing Opioids with Abuse-Deterrent Properties Have New FDA Guidance to Follow
Guidance is specifically for companies submitting ANDAs for generic solid oral opioid drug products.
Men in the UK Will Be Able to Buy Viagra Over the Counter Next May
Viagra reclassified as an over-the-counter medicine.
No Clinically Meaningful Difference: The Upward Trend of Biosimilars
Following a string of approvals, biosimilars are positioned to go the way of generics.
Moving Beyond Monoclonal Antibodies
Next-generation antibody therapeutics are designed to provide improved specificity, efficacy and safety when compared to conventional monoclonal antibodies.
Pharma’s Automation Index on the Rise
Call it the automation of everything — a hands-off approach will permeate supply chains in the near future.
Holiday Program Brings Hope Home to Lung Cancer Patients
Volunteers wrap presents, decorate trees, sing carols, hang outdoor holiday lights, write cards and bring much needed help to lung cancer patients throughout the country.
Nice Insight Research
Chain Annual Study
- Managing the Complexities of Outbound Clinical Drug Distribution By: Wes Wheeler, Ariette van Strien, Marken
- Segregation in the Design of Gene Therapy Manufacturing Facilities Peter Walters, CRB USA
- Building the Foundation of Japan’s Premier CDMO Jun Yokohama, Bushu Pharmaceuticals Ltd., Toshio Yoshioka, Spera Pharma, Inc.
- Developing Targeted Potassium Channel Openers for CNS-Related Therapeutics Doug Krafte, Ph.D., Neil Castle, Ph.D., Aaron Gerlach, Ph.D., Icagen
- Right-First-Time Innovation Approach Drives Continual Investment Adam Kujath, Alcami
- Achieving Efficient Pharmaceutical Synthesis with Process Intensification Stéphane Laurent, Servier CDMO
- Achieving a High Level of Customer Service Through Lean Quality Management Warren Horton, Avara Pharmaceutical Services
Pharma's Almanac TVView All Video
Road To BIO: Coming Soon To Your Screen
That’s Nice is producing a film based on the Road To BIO, for release in 2017. Watch the teaser trailer to get a taster of all the behind-the-scenes stories, character insights, and what went into the project.
Facility Expansion at Abzena
John Manzello, President, US, Abzena
Attracting Investors and Shortening Development Times
James C. Greenwood, President & CEO, Biotechnology Innovation Organization (BIO)
Providing a Complete Modular Solution
George Wiker, Executive Director, AES
Bringing Bioscience to Space
Bill Goodman, Ph.D., Vice President, SCORPIO-V, a Division of HNu Photonics
Devin Ridgley, Project Scientist, SCORPIO-V, a Division of HNu Photonics
LatestView All Latest
Dec 12, 2017 1:27:27 PM PAO-M12-17-NI-017
Dec 8, 2017 10:36:14 AM PAO-M12-17-NI-013
Dec 8, 2017 10:31:13 AM PAO-M12-17-NI-012
Dec 8, 2017 10:20:38 AM PAO-M12-17-NI-011
Dec 8, 2017 10:17:37 AM PAO-M12-17-NI-010
Dec 7, 2017 3:13:06 PM PAO-M12-17-NI-007
Dec 5, 2017 1:59:20 PM PAO-M12-17-NI-006
International Society for Cellular Therapy Supports New FDA Policy Framework for Regenerative MedicineDec 1, 2017 10:27:28 AM PAO-M12-17-NI-004
Dec 1, 2017 10:22:20 AM PAO-M12-17-NI-003
Dec 1, 2017 10:17:21 AM PAO-M12-17-NI-002
Dec 1, 2017 10:01:21 AM PAO-M12-17-NI-001
New Ferring and Aché Laboratórios Farmacêuticos Facility Opens to Optimise Drug Delivery Using NanotechnologyNov 30, 2017 2:23:45 PM PR-M11-17-NI-018
Nov 30, 2017 2:23:30 PM PR-M11-17-NI-017
Nov 30, 2017 11:11:43 AM PAO-M11-17-NI-052
Nov 30, 2017 10:48:22 AM PAO-M11-17-NI-049
Nov 28, 2017 1:02:19 PM PAO-M11-17-NI-047
Nov 28, 2017 1:01:06 PM PAO-M11-17-NI-045
Nov 28, 2017 1:00:19 PM PAO-M11-17-NI-046
Nov 24, 2017 3:01:00 PM PAO-M11-17-NI-042
TOPICSView All Topics
Dec 12, 2017 10:40:40 AM
Dec 12, 2017 10:22:30 AM
Dec 12, 2017 10:02:33 AM
Dec 12, 2017 9:59:33 AM
Dec 8, 2017 11:41:38 AM
The contract manufacturing market for antibody-drug conjugates has huge potential, but an extraordinary range of capabilities is essential to be in the game. We spoke to some of the players to find out all about ADCs.
By the Numbers
2017 Top 5 Industry Leaders
Now stronger than ever, Marken needed a bold visual direction to illustrate its expanding breadth of services and ongoing commitment to personalized medicine.
Nice Insight Overview